Study Stopped
Study was completed at other sites
Ethnic/Racial Differences in Metabolism and DNA Adduct Formation
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
The study will investigate the role of 1,3-butadiene metabolic activation and deactivation in lung cancer risk among various ethnic/racial groups. This project will require urine samples from smokers and nonsmokers from the three ethnic/racial groups recruited by the Clinical and Biomarker Core for the analysis of 1,3-butadiene DNA adducts. Data on nicotine intake (urinary TNE) in these subjects as well as in 400 lung cancer cases and 400 controls from Project 1 will be also required for this project.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2020
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2018
CompletedFirst Posted
Study publicly available on registry
February 5, 2018
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedOctober 5, 2020
September 1, 2020
2.7 years
January 23, 2018
September 30, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Butadiene-DNA adducts in different ethnic groups
Investigate ethnic differences in butadiene-DNA adducts in smokers belonging to different ethnic groups.
Day 1 & 2
Butadiene-DNA adduct load in smokers with lung cancer
Investigate the association between butadiene-DNA adduct load and lung cancer development in smokers.
Day 1 & 2
Polymorphisms of carnicogen metabolizing genes
Examine how polymorphisms of carcinogen metabolizing genes influence metabolic inactivation, DNA adduct formation/repair, and toxicity of butadiene-derived epoxides.
Day 1 & 2
Study Arms (3)
Japanese American
Two parents of Japanese descent
Non-Hispanic Whites
Two parents of non-Hispanic white descent
Native Hawaiians
At least one parent of Hawaiian descent
Interventions
One to two home visits where tobacco use and medical history and biological samples will be collected including blood, buccal cells and urine
Eligibility Criteria
Approximately 300 smokers will be recruited from the Multiethnic Cohort (MEC) study or the general population in Hawai'i
You may qualify if:
- One of the three targeted ethnic groups:
- Japanese American - two parents of Japanese descent
- Non-Hispanic Whites - two parents of non-Hispanic white descent
- Native Hawaiians will include individuals with at least one parent of Hawaiian descent;
- Smoke 5 cigarettes per day over the past three months;
- \>21 years of age;
- Consumes 14 or fewer drinks of alcohol per week;
- Generally stable and good health (determined by review of medical history);
- Able to provide written voluntary consent before performance of any study related procedure.
You may not qualify if:
- Current use of other nicotine containing products for \> 4 times per month (and no use of any nicotine-containing products except cigarettes for 2 weeks prior to their study visits);
- Acute or uncontrolled medical or psychiatric conditions;
- Currently taking any medications that affect relevant metabolic enzymes or anti- inflammatory medications such as ibuprofen (this will be reviewed by study investigators on a case-by-case basis);
- Active infection (e.g., influenza, cold, respiratory infection, sinus infection) at the time of the visit;
- Pregnant or nursing or planning on becoming pregnant during the study;
- Unable to read and understand English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dorothy Hatsukami, Ph.D.
University of Minnesota, Department of Psychiatry
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2018
First Posted
February 5, 2018
Study Start
October 1, 2020
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
October 5, 2020
Record last verified: 2020-09